Biblio

Export 1190 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study., J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
J. C. de la Torre, Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations., J Alzheimers Dis, vol. 57, no. 2, pp. 353-371, 2017.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review., J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
F. Sellal, Wallon, D., Martinez-Almoyna, L., Marelli, C., Dhar, A., Oesterlé, H., Rovelet-Lecrux, A., Rousseau, S., Kourkoulis, C. E., Rosand, J., DiPucchio, Z. Y., Frosch, M., Gombert, C., Audoin, B., Miné, M., Riant, F., Frebourg, T., Hannequin, D., Campion, D., Greenberg, S. M., Tournier-Lasserve, E., and Nicolas, G., APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review., J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
L. Calderón-Garcidueñas and de la Monte, S. M., Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females., J Alzheimers Dis, vol. 58, no. 3, pp. 613-630, 2017.
M. Basta, Zaganas, I., Simos, P., Koutentaki, E., Dimovasili, C., Mathioudakis, L., Bourbouli, M., Panagiotakis, S., Kapetanaki, S., and Vgontzas, A., Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment., J Alzheimers Dis, vol. 79, no. 2, pp. 763-771, 2021.
E. Dorey, Bamji-Mirza, M., Najem, D., Li, Y., Liu, H., Callaghan, D., Walker, D., Lue, L. - F., Stanimirovic, D., and Zhang, W., Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro., J Alzheimers Dis, vol. 57, no. 4, pp. 1265-1279, 2017.
R. Cardoso, Lemos, C., Oliveiros, B., Almeida, M. Rosário, Baldeiras, I., Pereira, C. Fragão, Santos, A., Duro, D., Vieira, D., Santana, I., and Oliveira, C. Resende, APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease., J Alzheimers Dis, vol. 78, no. 2, pp. 587-601, 2020.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid., J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
R. López-Higes, Rodríguez-Rojo, I. C., Prados, J. M., Montejo, P., Del-Río, D., Delgado-Losada, M. Luisa, Montenegro, M., López-Sanz, D., and Barabash, A., APOE ε4 Modulation of Training Outcomes in Several Cognitive Domains in a Sample of Cognitively Intact Older Adults., J Alzheimers Dis, vol. 58, no. 4, pp. 1201-1215, 2017.
R. López-Higes, Rodríguez-Rojo, I. C., Prados, J. M., Montejo, P., Del-Río, D., Delgado-Losada, M. Luisa, Montenegro, M., López-Sanz, D., and Barabash, A., APOE ε4 Modulation of Training Outcomes in Several Cognitive Domains in a Sample of Cognitively Intact Older Adults., J Alzheimers Dis, vol. 58, no. 4, pp. 1201-1215, 2017.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points., J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
X. Tang, Holland, D., Dale, A. M., and Miller, M. I., APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters., J Alzheimers Dis, vol. 47, no. 3, pp. 645-60, 2015.
E. Del Valle, Navarro, A., Martínez-Pinilla, E., Torices, S., and Tolivia, J., Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?, J Alzheimers Dis, vol. 53, no. 2, pp. 639-50, 2016.
K. Bourgade, Dupuis, G., Frost, E. H., and Fülöp, T., Anti-Viral Properties of Amyloid-β Peptides., J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Vandermeeren, Borgers, M., Van Kolen, K., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., Delbroek, L., Marreiro, A., Donck, L. Ver, Sousa, C., Nanjunda, R., Lacy, E., Van De Casteele, T., Van Dam, D., De Deyn, P. Paul, Kemp, J. A., Malia, T. J., and Mercken, M. H., Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo., J Alzheimers Dis, vol. 65, no. 1, pp. 265-281, 2018.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers., J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
A. Ivan B. Posis, Tarraf, W., Gonzalez, K. A., Soria-Lopez, J. A., Léger, G. C., Stickel, A. M., Daviglus, M. L., Lamar, M., Zeng, D., and González, H. M., Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging., J Alzheimers Dis, vol. 86, no. 1, pp. 53-65, 2022.
L. M. Giil, Vedeler, C. A., Kristoffersen, E. K., Nordrehaug, J. Erik, Heidecke, H., Dechend, R., Schulze-Forster, K., Muller, D. N., von Goetze, V. S., Cabral-Marques, O., Riemekasten, G., Vogelsang, P., Nygaard, S., Lund, A., and Aarsland, D., Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function., J Alzheimers Dis, vol. 59, no. 3, pp. 929-939, 2017.

Pages